4fu7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (02:54, 21 November 2024) (edit) (undo)
 
(One intermediate revision not shown.)
Line 1: Line 1:
==Crystal Structure of the Urokinase==
==Crystal Structure of the Urokinase==
-
<StructureSection load='4fu7' size='340' side='right' caption='[[4fu7]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
+
<StructureSection load='4fu7' size='340' side='right'caption='[[4fu7]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4fu7]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4FU7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4FU7 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4fu7]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4FU7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4FU7 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1UP:2-[(7-CARBAMIMIDOYL-2-METHOXYNAPHTHALEN-1-YL)OXY]ACETAMIDE'>1UP</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4fu8|4fu8]], [[4fu9|4fu9]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1UP:2-[(7-CARBAMIMIDOYL-2-METHOXYNAPHTHALEN-1-YL)OXY]ACETAMIDE'>1UP</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PLAU ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4fu7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4fu7 OCA], [https://pdbe.org/4fu7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4fu7 RCSB], [https://www.ebi.ac.uk/pdbsum/4fu7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4fu7 ProSAT]</span></td></tr>
-
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] </span></td></tr>
+
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4fu7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4fu7 OCA], [http://pdbe.org/4fu7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4fu7 RCSB], [http://www.ebi.ac.uk/pdbsum/4fu7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4fu7 ProSAT]</span></td></tr>
+
</table>
</table>
-
== Disease ==
+
 
-
[[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[http://omim.org/entry/601709 601709]]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref>
+
==See Also==
-
== Function ==
+
*[[Urokinase 3D Structures|Urokinase 3D Structures]]
-
[[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
+
-
== References ==
+
-
<references/>
+
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
-
[[Category: U-plasminogen activator]]
+
[[Category: Large Structures]]
-
[[Category: Giranda, V]]
+
[[Category: Giranda V]]
-
[[Category: Kang, Y N]]
+
[[Category: Kang YN]]
-
[[Category: Nienaber, V]]
+
[[Category: Nienaber V]]
-
[[Category: Stuckey, J A]]
+
[[Category: Stuckey JA]]
-
[[Category: Hydrolase]]
+
-
[[Category: Hydrolase-hydrolase inhibitor complex]]
+

Current revision

Crystal Structure of the Urokinase

PDB ID 4fu7

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4fu7"
Personal tools